Menu Close

Sunfa Reneau was injured in a car accident caused by Andre Hernandez on June 3, 2020. Two days later she was treated at Long Beach Memorial Medical Center. She presented her Medi-Cal card, and the hospital’s admissions manager confirmed her eligibility. The hospital billed Medi-Cal for some of the services it provided, but $7,683 in charges for other services were never submitted to Medi-Cal and reportedly remain unpaid.

On July 24, 2020, the hospital’s attorneys, Yoshida & Garcia, Inc., wrote to Hernandez’s auto insurer, Alliance United, giving notice of a hospital lien under Civil Code § 3045.5 of the Hospital Lien Act (HLA) and threatening suit over the unpaid $7,683. In March 2021, Reneau settled her claim against Hernandez for $7,500, to be paid by Alliance United. The law firm continued to pursue the lien, and the insurer withheld Reneau’s settlement funds.

Reneau filed suit in June 2021, and the defendants removed the case to federal court. Her operative third amended complaint asserted putative class claims under federal and California debt collection law and the Unfair Competition Law (UCL), Business and Professions Code § 17200 et seq. In May 2024, the federal court dismissed the federal debt collection claim and remanded the remaining claims to the Los Angeles County Superior Court.

Judge Kenneth R. Freeman then sustained the defendants’ demurrer to the state debt collection and UCL claims without leave to amend. The court reasoned that the HLA and the Medi-Cal Act could be harmonized to permit the lien, and that the UCL could not be used to attack the HLA’s “safe harbor.” Judgment was entered, and Reneau appealed, challenging only the dismissal of her UCL claim.

In the published case of Reneau v. Yoshida & Garcia, Inc., No. B345787 (November 2026), the Second District Court of Appeal, Division Five, reversed the judgment and the order sustaining the demurrer to the UCL claim, and remanded for the case to proceed on that claim alone. The court held that a hospital may not assert an HLA lien for services provided to a Medi-Cal beneficiary, that the lien here was therefore invalid, and that the invalid lien can support a UCL claim.

Reviewing the demurrer de novo and accepting the complaint’s well-pleaded facts as true, the court began with the HLA, Civil Code § 3045.1 et seq., which gives hospitals a lien against a patient’s recovery from a third-party tortfeasor. In Parnell v. Adventist Health System/West (2005) 35 Cal.4th 595, the California Supreme Court held that the lien “requires the existence of an underlying debt owed by the patient to the hospital.” If the patient owes nothing, no lien attaches. (Parnell also disapproved Swanson v. St. John’s Regional Medical Center (2002) 97 Cal.App.4th 245 to the extent it conflicted.)

The court then turned to the Medi-Cal framework. Federal Medicaid law, 42 U.S.C. § 1396a, strictly limits how providers are reimbursed. The Medi-Cal Act requires providers to bill Medi-Cal and bars them from seeking payment from beneficiaries or from anyone other than the state or a qualifying third-party payor (Welfare and Institutions Code § 14019.4). The right to recover from liable third parties belongs to the state agency, not the provider, and beneficiaries assign their recovery rights to the state rather than to providers (Welfare and Institutions Code § 14124.71). As the Supreme Court noted in Olszewski v. Scripps Health (2003) 30 Cal.4th 798, Medicaid beneficiaries need not assign to providers their right to recover from third parties.

Putting the two together, the court found that the defendants offered no reason why Parnell’s debt requirement should not apply in the Medi-Cal setting. Reneau owed the hospital nothing, and a settling tortfeasor is not a “third-party payor” within the meaning of section 14019.4. The HLA lien therefore conflicted with the Medi-Cal Act and was invalid.

On the UCL claim, the court acknowledged that the statute’s reach over unlawful, unfair, and fraudulent practices is broad but cannot be used to attack a legislative safe harbor. Under Cel-Tech Communications, Inc. v. Los Angeles Cellular Telephone Co. (1999) 20 Cal.4th 163, plaintiffs “may not use the general unfair competition law to assault that harbor.” But the HLA provides no safe harbor here, the court explained, because the defendants had no authority under the HLA to assert the lien in the first place.

The court also rejected the argument that its holding should apply only prospectively. Because the governing statutes and cases are long-standing, the ruling simply applies existing law to new facts. The court distinguished Olszewski, which involved a statute that was itself preempted; here, the HLA is facially valid and only its use against a Medi-Cal beneficiary was improper. The court further held that Reneau did not need a separate declaratory relief cause of action, since her complaint already sought a judicial declaration that the practices were prohibited, and it deemed the defendants’ litigation privilege argument forfeited because it was not presented under a proper heading.

For hospitals, lien claimants, and liability and auto insurers handling settlements with Medi-Cal patients, the published ruling makes clear that a provider who accepts a Medi-Cal patient cannot sidestep Medi-Cal billing rules by asserting an HLA lien against the patient’s third-party recovery, and that doing so may expose the provider and its collection counsel to UCL liability.